FOXP3 and autoimmune disease: The targeted inhibition of UHRF1 by DPPA3 or PRMT6 proteins may mitigate the suppressive impact of DNMTs on FOXP3+Tregs, thereby offering promising prospects for the treatment of autoimmune diseases (122, 123).